News

NicOx is seeking approval for an indication for the relief of the signs and symptoms of primary osteoarthritis. This follows the acceptance for filing of a New Drug

Initially, the company plans to market IoGen through its own retail web site, which is currently being developed by Atech Solutions. In preparation of the launch, Symbollon has

Ofatumumab is a human monoclonal antibody with a mode of action. It targets a part of CD20 molecule encompassing an epitope in the small loop (Teeling et al

As per the current collaboration agreement with the University of Liverpool, HealthLinx licensed in key biomarkers that appear to have utility in the future development of OvPlex ovarian

The drug delivery system contains active pharmaceutical ingredients (API). Taken orally, the wafer-thin StripTabs dissolve on the tongue immediately. This type of medication, based on a starch and

UCB, a Belgium-based biopharmaceutical company, has worked with the Department of Health to provide an alternative for people with RA through a patient access scheme. In clinical studies,

The company claims that the increased capacity is of particular benefit to high throughput laboratories, extending processing time and increasing laboratory productivity. Concentrated reagent wedges liberate space on

Under the terms of the transaction, Martek will pay consideration of $200m, subject to working capital adjustments, of which $120m will be paid from its current cash reserves

The agreement gives Ferrer inCode, a biotech subsidiary of Grupo Ferrer Internacional, the right to sell and market ADtect initially in Germany, Belgium, the Netherlands, Luxemburg, France, Italy,